Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?

This is a cross-sectional study of 29 published cases of acute myopericarditis following COVID-19 mRNA vaccination. The most common presentation was chest pain within 1–5 days after the second dose of mRNA COVID-19 vaccination. All patients had an elevated troponin. Cardiac magnetic resonance imagin...

Full description

Bibliographic Details
Published in:	Children
Main Authors:	Bibhuti B. Das, William B. Moskowitz, Mary B. Taylor, April Palmer
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Subjects:	COVID-19 vaccine myocarditis pericarditis
Online Access:	https://www.mdpi.com/2227-9067/8/7/607

Similar Items

Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis
by: Jaehyeong Cho, et al.
Published: (2025-08-01)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
by: Minglong Li, et al.
Published: (2022-08-01)

Myocarditis and pericarditis in patients with COVID-19
by: Jassim Zaheen Shah, et al.
Published: (2020-01-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

Myocarditis and pericarditis in young patients following Campylobacter jejuni enterocolitis infection: a systematic review of case studies
by: Katharine Sanicola, et al.
Published: (2024-11-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
by: Wei-Ju Su, et al.
Published: (2023-06-01)

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
by: Joana Tome, et al.
Published: (2023-04-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
by: Laura C. Zwiers, et al.
Published: (2025-07-01)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
by: Abdallah Alami, et al.
Published: (2022-05-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Pericarditis due to an unusual microorganismin an immunocompromised patient
by: Flora Özkalaycı, et al.
Published: (2019-09-01)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
by: Giuseppe Calcaterra, et al.
Published: (2021-09-01)

Pediatric Myocarditis: What Have We Learnt So Far?
by: Elettra Pomiato, et al.
Published: (2022-05-01)

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
by: Shreeya Patel, et al.
Published: (2022-06-01)

Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study
by: Guihong Liu, et al.
Published: (2023-12-01)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
by: Rima Hajjo, et al.
Published: (2021-10-01)

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
by: Zaeema Naveed, et al.
Published: (2024-03-01)

Life-threatening constrictive pericarditis accompanied by synthetic cannabinoid use: A case report and literature review
by: Mahsa Behnemoon, et al.
Published: (2024-07-01)

Cardiomyopathy Associated with Anti-SARS-CoV-2 Vaccination: What Do We Know?
by: Alfredo Parra-Lucares, et al.
Published: (2021-12-01)

Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database
by: Guojing Yao, et al.
Published: (2025-08-01)

EXPERIMENTAL PERICARDITIS
by: E.A. LOZOVSKAYA, et al.
Published: (2023-12-01)

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
by: Sophie H. Bots, et al.
Published: (2022-11-01)

High dose cytarabine induced myopericarditis: When the heart debilitates but the fight against cancer must be strong
by: Villa-Saldarriaga, María P, et al.
Published: (2022-04-01)

Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease With Viral Infection: Have We Found the Holy Grail?
by: Jun-Jun Yeh, et al.
Published: (2022-06-01)

Purulent Bacterial Pericarditis
by: Emily S. Lee, MD, et al.
Published: (2024-04-01)

The association of myocardial strain with cardiac magnetic resonance and clinical outcomes in patients with acute myocarditis
by: Alexandre M. Soeiro, et al.
Published: (2023-07-01)

Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine
by: O. V. Blagova, et al.
Published: (2020-12-01)

Tuberculous Pericarditis—Own Experiences and Recent Recommendations
by: Małgorzata Dybowska, et al.
Published: (2022-03-01)

COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
by: Bibhuti B Das
Published: (2020-12-01)

Pericarditis Purulenta
by: Máximo Rossell Salinas
Published: (1992-06-01)

Fibrinolytic Therapy in Purulent Pericarditis
by: Małgorzata Dybowska, et al.
Published: (2023-01-01)

Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
by: François Roubille, et al.
Published: (2022-06-01)

Purulent pericarditis as a complication of pneumonia in an infant. Clinical case report
by: Diego Alejandro Lozano Espinosa, et al.
Published: (2018-01-01)

Pericarditis Purulenta en un postoperado de Colecistectomía .Presentación de caso Purulent pericarditis in a postoperative cholecystectomy. Case presentation
by: Carlos Enrique Salgado Fuentes, et al.
Published: (2021-01-01)